352 related articles for article (PubMed ID: 31980703)
1. Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris.
Shaban S; Patel M; Ahmad A
Sci Rep; 2020 Jan; 10(1):1162. PubMed ID: 31980703
[TBL] [Abstract][Full Text] [Related]
2. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
[No Abstract] [Full Text] [Related]
3. In vitro activity of natural phenolic compounds against fluconazole-resistant Candida species: a quantitative structure-activity relationship analysis.
Gallucci MN; Carezzano ME; Oliva MM; Demo MS; Pizzolitto RP; Zunino MP; Zygadlo JA; Dambolena JS
J Appl Microbiol; 2014 Apr; 116(4):795-804. PubMed ID: 24387763
[TBL] [Abstract][Full Text] [Related]
4. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
Jafri H; Ahmad I
J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
[TBL] [Abstract][Full Text] [Related]
5. Alkylphenol Activity against Candida spp. and Microsporum canis: A Focus on the Antifungal Activity of Thymol, Eugenol and O-Methyl Derivatives.
Fontenelle RO; Morais SM; Brito EH; Brilhante RS; Cordeiro RA; Lima YC; Brasil NV; Monteiro AJ; Sidrim JJ; Rocha MF
Molecules; 2011 Jul; 16(8):6422-31. PubMed ID: 25134762
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7.
Arendrup MC; Jørgensen KM; Hare RK; Chowdhary A
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844005
[TBL] [Abstract][Full Text] [Related]
8. The Two-Component Response Regulator Ssk1 and the Mitogen-Activated Protein Kinase Hog1 Control Antifungal Drug Resistance and Cell Wall Architecture of Candida auris.
Shivarathri R; Jenull S; Stoiber A; Chauhan M; Mazumdar R; Singh A; Nogueira F; Kuchler K; Chowdhary A; Chauhan N
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055262
[No Abstract] [Full Text] [Related]
9. Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti-
Miranda-Cadena K; Dias M; Costa-Barbosa A; Collins T; Marcos-Arias C; Eraso E; Pais C; Quindós G; Sampaio P
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468460
[TBL] [Abstract][Full Text] [Related]
10. Effect of two monoterpene phenols on antioxidant defense system in Candida albicans.
Khan A; Ahmad A; Ahmad Khan L; Padoa CJ; van Vuuren S; Manzoor N
Microb Pathog; 2015 Mar; 80():50-6. PubMed ID: 25681060
[TBL] [Abstract][Full Text] [Related]
11. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
[TBL] [Abstract][Full Text] [Related]
12. Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans.
Messier C; Grenier D
Mycoses; 2011 Nov; 54(6):e801-6. PubMed ID: 21615543
[TBL] [Abstract][Full Text] [Related]
13. Enhanced activity of antifungal drugs using natural phenolics against yeast strains of Candida and Cryptococcus.
Faria NC; Kim JH; Gonçalves LA; Martins Mde L; Chan KL; Campbell BC
Lett Appl Microbiol; 2011 May; 52(5):506-13. PubMed ID: 21332761
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of in vitro activity of carvacrol against Candida albicans strains.
Vardar-Unlu G; Yağmuroğlu A; Unlu M
Nat Prod Res; 2010 Jul; 24(12):1189-93. PubMed ID: 20582812
[TBL] [Abstract][Full Text] [Related]
15. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris.
Eldesouky HE; Li X; Abutaleb NS; Mohammad H; Seleem MN
Int J Antimicrob Agents; 2018 Dec; 52(6):754-761. PubMed ID: 30145250
[TBL] [Abstract][Full Text] [Related]
16. Interaction of carvacroland voriconazole against drug - resistant Candida strains isolated from patients with candidiasis.
Sharifzadeh A; Shokri H; Abbaszadeh S
J Mycol Med; 2019 Apr; 29(1):44-48. PubMed ID: 30554935
[TBL] [Abstract][Full Text] [Related]
17. Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.
Wurster S; Bandi A; Beyda ND; Albert ND; Raman NM; Raad II; Kontoyiannis DP
J Antimicrob Chemother; 2019 Jul; 74(7):1904-1910. PubMed ID: 31225606
[TBL] [Abstract][Full Text] [Related]
18. An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris.
Iyer KR; Camara K; Daniel-Ivad M; Trilles R; Pimentel-Elardo SM; Fossen JL; Marchillo K; Liu Z; Singh S; Muñoz JF; Kim SH; Porco JA; Cuomo CA; Williams NS; Ibrahim AS; Edwards JE; Andes DR; Nodwell JR; Brown LE; Whitesell L; Robbins N; Cowen LE
Nat Commun; 2020 Dec; 11(1):6429. PubMed ID: 33353950
[TBL] [Abstract][Full Text] [Related]
19. Fungicidal activity of human antimicrobial peptides and their synergistic interaction with common antifungals against multidrug-resistant Candida auris.
Shaban S; Patel M; Ahmad A
Int Microbiol; 2023 May; 26(2):165-177. PubMed ID: 36329309
[TBL] [Abstract][Full Text] [Related]
20. Novel properties of Hippophae rhamnoides L. twig and leaf extracts - anti-virulence action and synergy with antifungals studied in vitro on Candida spp. model.
Sadowska B; Budzyńska A; Stochmal A; Żuchowski J; Różalska B
Microb Pathog; 2017 Jun; 107():372-379. PubMed ID: 28428132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
